Project Name :An open-label, randomized, multi-center, two-way crossover, multiple-dose bioequivalence study of two formulations of risperidone 37,5 mg prolonged release suspension for injection in stable schizophrenic patients
Donor Organization :SanaCliss
Budget:შესრულების შესაბამისი
Grant number :TEVA/RISPE05HL17EU99501/Inst
Direction :8 Medical Sciences
Subdirection :8-317 Psychiatrics
Key word :Risperidone Prolonged Form
Description :Prolonged-acting risperidone, effective in patients with schizophrenia